JUVE Patent

Simon focuses on contentious patent work across a range of industries, with a particular emphasis on the life sciences sector. He also has experience in pharmaceutical regulatory work.

Simon represents clients in the U.K. Patents Court, the U.K. Court of Appeal, the Unified Patents Court (UPC) and at the European Patent Office, and regularly cooperates with lawyers conducting parallel litigation in the US and other European jurisdictions.

Current cases include representing Pfizer in UK litigation against Moderna and GSK relating to COVID-19 as well as cases for Pfizer in the UPC against GSK (Hague Local Division) and Moderna (Hamburg Local Division).

He advises pharmaceutical clients on patent infringement and validity, launch strategy, preliminary injunction applications, and pharmaceutical regulatory work.

In 2021 he was coauthor of “A User’s Guide to Intellectual Property in the Life Sciences” (with Paul England).

Outside of law, Simon lectures and writes regularly and is the U.K. correspondent of the “Bioscience Law Review” and the U.K. contributor to “Pharmaceutical, Biotechnology and Chemical Inventions” (published by Oxford University Press).